An EU-led coronavirus fundraiser fell short of its goal. The U.S.'s lack of participation didn't help.
A European Union-led fundraiser for coronavirus vaccines, treatments, and diagnostics failed to meet its 7.5 billion euro goal Monday, and the United States might be one reason why.
The effort was meant to be global, but the U.S. and Russia didn't participate. While their absences undoubtedly contributed to the failure (7.4 billion euros were raised, so the end result wasn't far behind the goal, though Politico notes funds that were already spent or allocated were also counted, raising questions about how much of the pledged money represented new resources), the larger concern may be that some countries will isolate the usage of a potential vaccine for its own citizens first.
U.S. officials didn't do much to dissuade that fear when they reportedly refused to offer an explanation as to why Washington wasn't involved in the summit.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
That said, President Trump on Sunday did say he doesn't care where a vaccine comes from and will consider it good news no matter what. Of course, that doesn't offer much clarity about the administration's intent should a vaccine first be developed in the U.S. Tim O'Donnell
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
How does the House Ethics Committee work?
In the Spotlight And what does that mean for Matt Gaetz?
By Joel Mathis, The Week US Published
-
The ultimate podcast list of 2024
The Week Recommends Some of the best podcast series released in the past year or so
By The Week UK Published
-
Crossword: December 26, 2024
The Week's daily crossword
By The Week Staff Published
-
Honda and Nissan in merger talks
Speed Read The companies are currently Japan's second and third-biggest automakers, respectively
By Peter Weber, The Week US Published
-
Taylor Swift wraps up record-shattering Eras tour
Speed Read The pop star finally ended her long-running tour in Vancouver, Canada
By Peter Weber, The Week US Published
-
Drake claims illegal boosting, defamation
Speed Read The rapper accused Universal Music of boosting Kendrick Lamar's diss track and said UMG allowed him to be falsely accused of pedophilia
By Rafi Schwartz, The Week US Published
-
'Wicked' and 'Gladiator II' ignite holiday box office
Speed Read The combination of the two movies revitalized a struggling box office
By Peter Weber, The Week US Published
-
Jussie Smollet conviction overturned on appeal
Speed Read The Illinois Supreme Court overturned the actor's conviction on charges of staging a racist and homophobic attack against himself in 2019
By Peter Weber, The Week US Published
-
Quincy Jones, music icon, is dead at 91
Speed Read The legendary producer is perhaps best known as the architect behind Michael Jackson's 'Thriller'
By Peter Weber, The Week US Published
-
OJ Simpson, star athlete tried for murder, dead at 76
Speed Read The former football hero and murder suspect lost his battle with cancer
By Rafi Schwartz, The Week US Published
-
Momofuku's 'Chili Crunch' trademark uproar
Speed Read The company's attempt to own the sole rights has prompted backlash
By Rafi Schwartz, The Week US Published